Comment
doi: 10.1183/13993003.01646-2015.
Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China
Affiliations
- PMID: 27132271
- DOI: 10.1183/13993003.01646-2015
Item in Clipboard
Comment
Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China
Eur Respir J.
2016 May.
Free article
No abstract available
Comment on
-
Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China.Eur Respir J. 2015 Jan;45(1):161-70. doi: 10.1183/09031936.00035114. Epub 2014 Sep 18. Eur Respir J. 2015. PMID: 25234807 Clinical Trial.
Similar articles
-
Linezolid for patients with multidrug-resistant tuberculosis/extensively drug-resistant tuberculosis in China.Drug Discov Ther. 2022 May 17;16(2):96-98. doi: 10.5582/ddt.2022.01024. Epub 2022 Apr 20. Drug Discov Ther. 2022. PMID: 35444071
-
Comparison of In Vitro Activity and MIC Distributions between the Novel Oxazolidinone Delpazolid and Linezolid against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis in China.Antimicrob Agents Chemother. 2018 Jul 27;62(8):e00165-18. doi: 10.1128/AAC.00165-18. Print 2018 Aug. Antimicrob Agents Chemother. 2018. PMID: 29844043 Free PMC article.
-
Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB.Eur Respir J. 2013 Jun;41(6):1386-92. doi: 10.1183/09031936.00124312. Epub 2012 Sep 20. Eur Respir J. 2013. PMID: 22997218
-
Linezolid for the treatment of drug-resistant tuberculosis in children: a review and recommendations.Tuberculosis (Edinb). 2014 Mar;94(2):93-104. doi: 10.1016/j.tube.2013.10.003. Epub 2013 Oct 27. Tuberculosis (Edinb). 2014. PMID: 24388605 Review.
-
A systematic review on extensively drug-resistant tuberculosis from 2009 to 2020: special emphases on treatment outcomes.Rev Esp Quimioter. 2023 Feb;36(1):30-44. doi: 10.37201/req/029.2022. Epub 2022 Dec 9. Rev Esp Quimioter. 2023. PMID: 36503203 Free PMC article.
Cited by
-
Linezolid for drug-resistant pulmonary tuberculosis.Cochrane Database Syst Rev. 2019 Mar 20;3(3):CD012836. doi: 10.1002/14651858.CD012836.pub2. Cochrane Database Syst Rev. 2019. PMID: 30893466 Free PMC article.
-
Mechanism underlying linezolid-induced peripheral neuropathy in multidrug-resistant tuberculosis.Front Pharmacol. 2022 Sep 9;13:946058. doi: 10.3389/fphar.2022.946058. eCollection 2022. Front Pharmacol. 2022. PMID: 36160387 Free PMC article.
-
Pre-Clinical Tools for Predicting Drug Efficacy in Treatment of Tuberculosis.Microorganisms. 2022 Feb 26;10(3):514. doi: 10.3390/microorganisms10030514. Microorganisms. 2022. PMID: 35336089 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
